NAOMI F. ROTHFIELD, M.D.
The use of immunosuppressive therapy in patients with systemic lupus erythematosus has become widespread during the past few years because of a number of reports describing its efficacy. These reports suggest that the use of cytotoxic drugs with corticosteroids leads to a more favorable outcome than treatment with corticosteroids alone. The enthusiastic use of several of these agents is now common and is not always reserved for those patients with life-threatening disease. Most of the literature upon which such enthusiasm is based consists of case reports or uncontrolled trials. Other studies have compared a group of patients recently treated with
ROTHFIELD NF. Immunosuppressive Therapy in Lupus Erythematosus. Ann Intern Med. 1975;83:727–728. doi: 10.7326/0003-4819-83-5-727
Download citation file:
Published: Ann Intern Med. 1975;83(5):727-728.
Lupus Erythematosus, Rheumatology.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use